Back to Search
Start Over
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
- Source :
-
Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Jul 10; Vol. 16 (1), pp. 159. Date of Electronic Publication: 2024 Jul 10. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 1758-9193
- Volume :
- 16
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Alzheimer's research & therapy
- Accession number :
- 38987826
- Full Text :
- https://doi.org/10.1186/s13195-024-01507-7